Abstract: Substituted aminoalkoxypyridines of the formula ##STR1## where R.sub.1 is CN or CF.sub.3 and L is dialkylamino or six-membered N heterocycle are disclosed. The compounds are useful as antihypertensive agents.
Abstract: The present application discloses certain 2-substituted propoxy-3-cyano-5-hydroxypyridines. The compounds have pharmaceutical activity e.g. as antihypertensives.
Type:
Grant
Filed:
February 10, 1981
Date of Patent:
February 15, 1983
Assignee:
Merck & Co., Inc.
Inventors:
John J. Baldwin, Gerald S. Ponticello, Stanley Vickers, Alfred Steuerwald
Abstract: A process for resolving a mixture of .alpha.-fluoromethylhistidine enantiomers is described. The process features use of an ester derivative of .alpha.-fluoromethylhistidine. Novel diastereoisomer salts of said derivative are also disclosed.
Type:
Grant
Filed:
July 21, 1980
Date of Patent:
August 31, 1982
Assignee:
Merck & Co., Inc.
Inventors:
Janos Kollonitsch, Leroy M. Perkins, George A. Doldouras, Stephen Marburg
Abstract: Novel alkylsubstituted 2-pyridylimidazoles, halosubstituted-2-pyridylbenzimidazoles, and 2-pyridylimidazopyridines are disclosed. The compounds have pharmaceutical utility as xanthine oxidase inhibitors and/or as antihypertensives.
Abstract: The present application discloses 2-substituted propoxy-3-cyano-5-RO-pyridines and intermediates therefor. The former compounds have pharmaceutical activity.
Abstract: The application discloses a pharmaceutical composition for treating hypertension containing (A) L-.alpha.-methyl-3,4-dihydroxyphenylalanine and (B) salicylamide, phenylglyoxal or L-ascorbic acid.
Abstract: Novel substituted (3-loweralkylamino-2-R.sub.1 O-propoxy)pyridines, their pharmaceutically acceptable salts, certain intermediates and their preparation are disclosed. These pyridines have pharmaceutically useful properties such as .beta.-adrenergic blocking activity.
Abstract: Organic chemical compounds based upon the urea molecule are disclosed which have potent gastric secretion inhibitory properties. The urea is substituted with a heterocyclic ring which may be substituted with one or more loweralkyl groups. The urea is also substituted with loweralkyl and a lower-alkylamino loweralkyl group. The compounds have profound effects on the inhibition of gastric secretions in the gastro-intestinal tract, and compositions for such uses are also disclosed.
Abstract: A process for preparing .alpha.-fluoromethyl amino acids is disclosed. The process utilizes SF.sub.4 and BF.sub.3 or AlCl.sub.3 in HF to effect the fluorination.
Abstract: Novel alkylsubstituted 2-pyridylimidazoles, halosubstituted-2-pyridylbenzimidazoles, and 2-pyridylimidazopyridines are disclosed. The compounds have pharmaceutical utility as xanthine oxidase inhibitors and/or as antihypertensive.
Abstract: Novel substituted (3-loweralkylamino-2-R.sub.1 O-propoxy)pyridines, their pharmaceutically acceptable salts, certain intermediates and their preparation are disclosed. These pyridines have pharmaceutically useful properties such as .beta.-adrenergic blocking activity.
Abstract: An apparatus and method for testing impairment of motor skills is described comprising an electrically conducting stylus to be passed by the person being tested down a series of slots in a planar solid, the slots being in a variety of geometric shapes and having an electrically conducting edge, the stylus and the slot edges being connected to timing and counting means.
Abstract: Di- and tri- substituted thiazoles, one substituent being a 3-amino-2-OR-propoxy group are disclosed. The thiazoles have .beta.-adrenergic blocking activity.